Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$45.42 USD
-0.76 (-1.65%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $45.94 +0.52 (1.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.89 |
EPS Last Quarter | -0.81 |
Last EPS Surprise | -5.19% |
ABR | 1.07 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.47 |
Next Year | -3.82 |
EPS (TTM) | -3.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.25M | 5.25M | 10.50M | 21.00M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 6.00M | 6.00M | 12.00M | 24.00M |
Low Estimate | 4.50M | 4.50M | 9.00M | 18.00M |
Year ago Sales | 0.00M | 0.74M | 11.58M | 10.50M |
Year over Year Growth Est. | NA | 609.46% | -9.33% | 100.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.89 | -0.97 | -3.47 | -3.82 |
# of Estimates | 10 | 9 | 11 | 11 |
Most Recent Consensus | -0.84 | -0.89 | -3.24 | -3.82 |
High Estimate | -0.81 | -0.83 | -3.16 | -3.19 |
Low Estimate | -0.95 | -1.04 | -4.29 | -4.28 |
Year ago EPS | -0.99 | -1.14 | -3.86 | -3.47 |
Year over Year Growth Est. | 10.10% | 14.91% | 10.10% | -10.14% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 7 | 7 | 10 | 8 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.89 | -0.97 | -3.47 | -3.82 |
7 Days Ago | -0.89 | -0.97 | -3.47 | -3.82 |
30 Days Ago | -0.89 | -0.97 | -3.47 | -3.82 |
60 Days Ago | -0.82 | -0.89 | -3.21 | -3.72 |
90 Days Ago | -0.80 | -0.82 | -3.12 | -3.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.89 | -0.97 | -3.47 | -3.82 |
Zacks Consensus Estimate | -0.89 | -0.97 | -3.47 | -3.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.81 | -0.70 | -1.14 | -0.99 | NA |
Estimate | -0.77 | -0.75 | -0.86 | -1.01 | NA |
Difference | -0.04 | 0.05 | -0.28 | 0.02 | -0.06 |
Surprise | -5.19% | 6.67% | -32.56% | 1.98% | -7.28% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more